| MiR-195 and its target SEMA6D regulate chemoresponse in breast cancer DE Baxter, LM Allinson, WS Al Amri, JA Poulter, A Pramanik, JL Thorne, ... Cancers 13 (23), 5979, 2021 | 25 | 2021 |
| Genomic and expression analyses define MUC17 and PCNX1 as predictors of chemotherapy response in breast cancer WS Al Amri, LM Allinson, DE Baxter, SM Bell, AM Hanby, SJ Jones, ... Molecular cancer therapeutics 19 (3), 945-955, 2020 | 16 | 2020 |
| Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants WS Al Amri, DE Baxter, AM Hanby, LF Stead, ET Verghese, JL Thorne, ... Breast cancer research and treatment 183, 607-616, 2020 | 15 | 2020 |
| Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response N Gwili, SJ Jones, WA Amri, IM Carr, S Harris, BV Hogan, WE Hughes, ... British journal of cancer 125 (7), 983-993, 2021 | 13 | 2021 |
| Differential Association between HER2/Neu and Angiogenesis in Breast Cancer W Al Amri, I Balachandran, S Thangirala, A Coleman, HAN El-Fawal, ... American Journal of Cancer Biology 1 (2), 62-76, 2013 | 3 | 2013 |
| BRCA1/2 Mutations and Outcomes Among Middle Eastern Patients with Early-Onset Breast Cancer in Oman W Al Amri, A Al-Amri, A Al Abri, TA Hughes, F Al Lawati The Oncologist, 2024 | | 2024 |
| SP4. 5 Expression of trans-membrane mucins is associated with poor outcomes after chemotherapy in breast cancer S Hebden, S Jones, W Al Amri, T Maisey, E Verghese, T Hughes British Journal of Surgery 110 (Supplement_6), znad241. 049, 2023 | | 2023 |
| A rare and challenging case of uterine mass successfully reported in a cervical smear W Al Amri, I Al Salmi, SK Al Nabhani, BS Al Hatrooshi CytoJournal 20, 2023 | | 2023 |
| Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer T Estrada, MA Cipriano, MF Silva, AM Abrantes, MF Botelho, D Martins, ... Sultan Qaboos University Medical Journal 21 (1), 2021 | | 2021 |
| Abstract P3-06-19: MUC17 and PCNX1 as mediators of chemotherapy response in breast cancer W Al Amri, E Verghese, L Stead, A Hanby, N Sharma, T Hughes Cancer Research 79 (4_Supplement), P3-06-19-P3-06-19, 2019 | | 2019 |
| The role of intra-tumoural heterogeneity in resistance to neoadjuvant chemotherapy in breast cancer WSH Al Amri University of Leeds, 2018 | | 2018 |
| American Journal of Cancer Biology WS Al Amri, I Balachandran, S Thangirala, A Coleman, HAN El-Fawal, ... | | 2013 |
